MRVI Q3 Revenue Rises, Net Loss Narrows; Price Target Raised to $9
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.